PT Ekadharma International, Tbk (EKAD) increase its capital expenditures worth between IDR 40 billion to IDR 50 billion. The Capex will add production capacity reached 192 million m2 per year for the expansion of two factories in Indonesia and Malaysia, the previous capacity of 305 million m2 per year. The company’s production capacity expansion, to meet the domestic demand as well as internationally. For the record, Ekadharma International’s consolidated net sales and profit includes worth at Rp 531 billion and Rp 47 billion respectively in 2015. Whereas the period of 1Q2016, each valued at Rp 138.6 billion and Rp 24.8 billion.
The performance of the 1Q2016 grow significantly each of 10.5% and 200%, compared to the same period of the previous year, each valued at Rp 125.4 billion and Rp 8.0 billion. Idnstocks.com project apart from cash, the company will conduct a number of bank loans to cover the expansion capital expenditures.